Navigation Links
Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction
Date:4/28/2009

BOTHELL, Wash., April 28 /PRNewswire/ -- Verathon(R) is pleased to announce the new BladderScan(R) BVM 9500 bladder volume instrument. Designed with Urologists in mind, the BVM 9500 measures both UEBW (ultrasound-estimated bladder weight) and bladder volume quickly and noninvasively to help diagnose bladder dysfunction, including BPH (benign prostatic hypertrophy) and BOO (bladder outlet obstruction). This new addition to the BladderScan(R) BVI 9000 series made its official debut at the AUA 2009 conference in Chicago, IL on April 25. (Verathon Booth # 4623).

(Logo: http://www.newscom.com/cgi-bin/prnh/20061011/SFW044LOGO)

Bladder Outlet Obstruction (BOO) is reported to be one of the most common urologic problems among elderly male patients.(1) To date, definitive diagnosis of BOO has been achieved through invasive, time-consuming urodynamics testing.(2) Clinical studies indicate that the mass of the bladder wall may correlate with BOO.(3) The BladderScan(R) BVM 9500 provides Ultrasound-Estimated Bladder Weight (UEBW), a noninvasive measurement of bladder wall mass, in addition to urinary bladder volume (PVR, or post-void residual).

Like all BladderScan(R) bladder volume instruments, the BVM 9500 does not require a sonographer and is easy for staff to learn and use.

"The BladderScan(R) BVM 9500 provides urologists with a quick, accurate, easy to use instrument for measuring bladder volume and UEBW," said Gerald McMorrow, CEO, Founder and Chairman of the Board of Verathon, Inc. "This means Urologists can efficiently task staff to take the measurements, while allowing them to spend their time on diagnosis, treatment plans and communicating with their patients."

The portable BladderScan(R) BVM 9500 uses noninvasive ultrasound to measure bladder volume and UEBW to help diagnose urinary retention, evaluate common urological conditions and prevent unnecessary catheterization. The BVM 9500 also uses patent-pending NeuralHarmonics(TM) Technology to measure bladder volume. NeuralHarmonics(TM) Technology helps achieve previously unattainable differentiation of the bladder, urine and hypo-echogenic regions such as the uterus.

When the scan button is pressed on the BladderScan(R) BVM 9500, the instrument measures ultrasonic reflections on multiple planes inside the body and produces a three dimensional image. Based on this image, the BVM 9500 calculates and displays the bladder volume and UEBW on the color console. The instrument offers aiming assistance to the user, on both the probe and the console. To facilitate training, there is a brief 6 minute video tutorial on measuring bladder volume and UEBW on the device.

Unlike other ultrasound machines the portable BVM 9500 is quick and exam results can be provided in a matter of minutes during an office visit. The BVM 9500 instrument can save exam data to HIPAA-compliant ScanPoint(R) online imaging technology from Verathon(R). ScanPoint(R) technology provides the ability to view, save and print bladder volume or UEBW measurement reports as well as to quickly and easily calibrate BladderScan(R) instruments online.

For more information, please visit www.verathon.com.

About Verathon Inc.

Verathon designs and manufactures reliable, state-of-the-art medical devices and services that offer a meaningful improvement in patient care to the health care community. The company's noninvasive BladderScan(R) instrument is the standard of care for noninvasive bladder volume measurement. The brand is found in over 80 countries in Urology and Primary Care practices, as well as Acute and Extended Care facilities. With the January 2006 acquisition of Saturn Biomedical Systems in Vancouver, Canada, Verathon(R) entered Anesthesiology, Critical Care and Emergency markets with the GlideScope(R) Video Laryngoscope (GVL(R)) brand. Verathon(R) is headquartered in Bothell, Washington and has over 400 employees worldwide. For more information, please visit www.verathon.com.

Media Contact: Rick Goetter, Brand Director - BladderScan(R), Verathon Medical, 425.867.1348, Ext. 5608. Alternate Contacts: Jane Mueller, VP of Marketing, Verathon Medical, 425.867.1348, Ext. 5600 and

Nansea Carmichael, Executive Assistant - Marketing, 425.867.1348, Ext. 5607.

BladderScan, NeuralHarmonics, ScanPoint, GlideScope, GVL, and Verathon are trademarks of Verathon Inc.

2009 Verathon Inc.

References:

1. Kelly, Christopher E. "The Relationship Between Pressure Flow Studies and Ultrasound-Estimated Bladder Wall Mass." Rev Urol. 2005; 7 (suppl 6): S29-S34.

2. Nitti, Victor W. "Introduction: Measurement of Bladder Mass Using Ultrasonography: A New Tool for Measuring Bladder Outlet Obstruction." Rev Urol. 2005; 7 (suppl 6): S1-S2; Nitti, Victor W. "Pressure Flow Urodynamic Studies: The Gold Standard for Diagnosing Bladder Outlet Obstruction." Rev Urol. 2005; 7 (suppl 6): S14-S21.

3. Tubaro, A., C. Manieri, et. al. "The Effect of Bladder Outlet Obstruction Treatment on Ultrasound-Determined Bladder Wall Thickness." Rev Urol. 2005; 7 (suppl 6): S35-S42.


'/>"/>
SOURCE Verathon Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms
2. GlideScope(R) Ranger Video Laryngoscope by Verathon(R) Awarded Airworthiness Certification by U.S. Army
3. Verathon(R) Offers Enhanced BladderScan(R) Instrument as Part of Continued Program to Eliminate Unnecessary Catheterizations, Decrease Urinary Tract Infections and Assist in Hospital Infection Control
4. Working Towards Counting Malaria Out Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide Resistance
5. AdEx Media Introduces RezActiv(TM)
6. Chill Cooling Towels Introduces Instant Relief for Hot Flashes and Night Sweats
7. PercSys Introduces Accordion CoAx(TM) Stone Control Device for Facilitating Percutaneous Kidney Stone Treatments
8. Lumenis Introduces the HoLEP Simulator and the PolyScope Disposable Ureteroscope at American Urology Association 2009 Annual Meeting
9. Medstrat Introduces Depots!
10. SynCardia Introduces New 12-lb Freedom Discharge Driver Designed to Provide Quality 'Lifestyle' for Total Artificial Heart Patients
11. The ASDS Introduces the First At-Home Skin Cancer Exam Kit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Colorado (PRWEB) , ... February 23, 2017 , ... ... Magazine, an exciting, new, interactive publication where generations converge and explore the world ... expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and ...
(Date:2/23/2017)... ... February 23, 2017 , ... Current Meditation , a ... franchising throughout the U.S. starting this spring. Current Meditation focuses on “meditation for ... mainstream. Current Meditation will be the first meditation concept in the U.S. offering ...
(Date:2/23/2017)... Lincoln, RI (PRWEB) , ... February 23, 2017 ... ... announced today a new partnership with the Rhode Island Consortium for Autism Research ... provide an opportunity for children with autism spectrum disorder (ASD) to see films ...
(Date:2/23/2017)... ... , ... CALNOC, the nation’s first and only nursing quality indicators database today ... Value and Collaboration – in Seattle, WA on October 23, 2017. , Dr. Gary ... in Seattle since 2000. In addition to his role at Virginia Mason, Dr. Kaplan ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Curemark, LLC ... safety and efficacy of CM-AT in children aged 3-8 with Autism, is now enrolling ... sites already enrolling children across the United States. , “There are currently no ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Strategies - 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis and ... Menopause market. The research answers the following questions: ... clinical attributes? How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... Feb. 23, 2017 AcelRx Pharmaceuticals, Inc. ... the development and commercialization of innovative therapies for ... it will release fourth quarter and yearly financial ... 2017. AcelRx management will host an investment-community conference ... Pacific Time) on March 2 nd 2017 ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The Global Endoscopy Market is poised to grow ... reach approximately $47.6 billion by 2025. This industry ... segments on global as well as regional levels presented in the ...
Breaking Medicine Technology: